Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Brainsway Ltd ADR (BWAY)

Brainsway Ltd ADR (BWAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 89,077
  • Shares Outstanding, K 16,650
  • Annual Sales, $ 31,790 K
  • Annual Income, $ -4,200 K
  • 60-Month Beta 1.18
  • Price/Sales 2.87
  • Price/Cash Flow N/A
  • Price/Book 2.17
Trade BWAY with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.02
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +85.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.72 +15.36%
on 04/26/24
6.18 -11.89%
on 05/07/24
+0.41 (+8.25%)
since 04/24/24
3-Month
4.61 +18.11%
on 04/18/24
6.82 -20.14%
on 03/06/24
-0.59 (-9.70%)
since 02/23/24
52-Week
1.49 +265.44%
on 05/26/23
7.61 -28.50%
on 01/08/24
+3.94 (+260.60%)
since 05/24/23

Most Recent Stories

More News
New Strong Sell Stocks for February 7th

AMD, BWAY and DCOM have been added to the Zacks Rank #5 (Strong Sell) List on February 7, 2023.

AMD : 166.36 (+3.70%)
DCOM : 18.77 (-0.48%)
BWAY : 5.40 (+0.93%)
New Strong Sell Stocks for February 1st

BWAY, CMAX and EQBK have been added to the Zacks Rank #5 (Strong Sell) List on February 1, 2023.

EQBK : 33.85 (+1.53%)
BWAY : 5.40 (+0.93%)
CMAX : 2.74 (-5.19%)
New Strong Sell Stocks for January 30th

BFC, CMAX and BWAY have been added to the Zacks Rank #5 (Strong Sell) List on January 30, 2023.

BFC : 81.37 (+2.30%)
BWAY : 5.40 (+0.93%)
CMAX : 2.74 (-5.19%)
New Strong Sell Stocks for January 26th

BWAY, INDB and CNX have been added to the Zacks Rank #5 (Strong Sell) List on January 26, 2023.

CNX : 24.83 (+0.89%)
INDB : 50.91 (-0.74%)
BWAY : 5.40 (+0.93%)
New Strong Sell Stocks for January 24th

ABM, BWAY and DXPE have been added to the Zacks Rank #5 (Strong Sell) List on January 24, 2023.

ABM : 46.87 (-0.74%)
DXPE : 49.60 (-3.52%)
BWAY : 5.40 (+0.93%)
New Strong Sell Stocks for January 19th

ABM, BWAY and DXPE have been added to the Zacks Rank #5 (Strong Sell) List on January 19, 2022.

ABM : 46.87 (-0.74%)
DXPE : 49.60 (-3.52%)
BWAY : 5.40 (+0.93%)
New Strong Sell Stocks for January 10th

BWAY, BWAY and AXL have been added to the Zacks Rank #5 (Strong Sell) List on January 10, 2023.

AXL : 7.41 (+1.23%)
ADNT : 27.24 (+1.19%)
BWAY : 5.40 (+0.93%)
BrainsWay Reports Second Quarter 2022 Financial Results and Operational Highlights

Revenue Growth of 14% Year-over-Year in Q2 2022 Conference call to be held today, August 10, 2022, at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Aug. ...

BWAY : 5.40 (+0.93%)
BrainsWay to Report Second Quarter Financial Results on August 10, 2022

BURLINGTON, Mass. and JERUSALEM, July 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...

BWAY : 5.40 (+0.93%)
Henry Schein (HSIC) to Report Q2 Earnings: What's in Store?

Henry Schein's (HSIC) Q2 performance will likely reflect continued strength in its dental and medical businesses.

HSIC : 71.72 (+0.28%)
ALC : 89.43 (-0.37%)
GKOS : 108.89 (+1.35%)
BWAY : 5.40 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder....

See More

Key Turning Points

3rd Resistance Point 5.79
2nd Resistance Point 5.67
1st Resistance Point 5.51
Last Price 5.40
1st Support Level 5.23
2nd Support Level 5.11
3rd Support Level 4.95

See More

52-Week High 7.61
Last Price 5.40
Fibonacci 61.8% 5.28
Fibonacci 50% 4.55
Fibonacci 38.2% 3.83
52-Week Low 1.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar